(Total Views: 480)
Posted On: 12/11/2023 10:01:39 AM
Post# of 148866
"HOOKIPA is responsible for advancing the HIV program through the completion of a Phase 1b clinical trial. Gilead has the exclusive right to assume further development of the program thereafter."
Hmm, it looks like more job offers coming for FDA senior employees. Additional funds may become more available for the FDA. That should make the FDA duty-bound to keep their boots on the necks of any small companies developing treatments that may compete.
Normally, I am not a conspiracy theorist. However, the FDA continually shows these bad optics. I guess we will see, soon, their reason for delaying Leronlimab's partial hold release (you know, the partial hold all of us are having problems understanding in the first place).
Read More: https://investorshangout.com/post/view?id=665...z8Lb1eF473
Hmm, it looks like more job offers coming for FDA senior employees. Additional funds may become more available for the FDA. That should make the FDA duty-bound to keep their boots on the necks of any small companies developing treatments that may compete.
Normally, I am not a conspiracy theorist. However, the FDA continually shows these bad optics. I guess we will see, soon, their reason for delaying Leronlimab's partial hold release (you know, the partial hold all of us are having problems understanding in the first place).
Read More: https://investorshangout.com/post/view?id=665...z8Lb1eF473
(7)
(0)Scroll down for more posts ▼
